Detalles de la búsqueda
1.
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
Cancer
; 130(5): 750-769, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37916800
2.
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.
Support Care Cancer
; 31(12): 637, 2023 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37847317
3.
Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Support Care Cancer
; 29(2): 833-840, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32500206
4.
A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102.
Support Care Cancer
; 29(1): 387-396, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32372176
5.
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.
Oncologist
; 24(5): 617-623, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30409792
6.
Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).
Oncologist
; 24(6): e284-e291, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30975921
7.
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.
N Engl J Med
; 375(2): 134-42, 2016 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27410922
8.
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602).
Oncologist
; 23(9): 1016-1023, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29674441
9.
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study.
Breast Cancer Res Treat
; 171(2): 325-334, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29789969
10.
Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).
Support Care Cancer
; 26(2): 643-650, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28921241
11.
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
Support Care Cancer
; 26(4): 1335-1343, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29164377
12.
Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort.
Cancer
; 123(21): 4193-4198, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28700816
13.
Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).
Breast Cancer Res Treat
; 166(3): 793-808, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28825227
14.
Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503).
Breast Cancer Res Treat
; 163(2): 391-398, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28283904
15.
A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.
Support Care Cancer
; 25(11): 3407-3416, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28551844
16.
MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy.
Support Care Cancer
; 24(3): 1071-8, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26248652
17.
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up.
Support Care Cancer
; 24(3): 1219-26, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26298334
18.
Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Support Care Cancer
; 29(11): 7129-7130, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480623
19.
Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).
Support Care Cancer
; 24(12): 5059-5068, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27534963
20.
5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.
Cancer
; 121(15): 2537-43, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25930719